ArticleJournal of animal science2025
The effects of supplemental brewers yeast on postprandial amino acid concentrations in healthy adult sled dogs.
Article in Journal of animal science, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Yeast has been used in animal systems to modulate the immune response and support gut health. Certain amino acids (AA) are reported to also exert positive effects on the gut, supporting the intestinal barrier and restoring mucosal immune homeostasis. The objective of this study was to evaluate the effects of brewers yeast on postprandial serum AA appearance in dogs. Nineteen privately owned domestic Siberian huskies and 1 Alaskan husky (9 females: 5 intact, 4 spayed; 11 males: 3 intact, 8 neutered), with an average age of 4.8 ± 2.6 yr and body weight (BW) of 25.6 ± 4.1 kg, were enrolled in this study. Ten dogs received a dry extruded control diet (Ctl) and 10 the Ctl diet top-dressed with yeast to receive a daily ß-glucan dose of 7 mg/kg BW (treatment, Trt) for 10 wk. At weeks -1, 2, 4, and 8 postprandial free AA concentrations were quantified. A fasted blood sample was collected, a meal was provided, followed by further blood sampling 1, 2, and 4 h post-meal. Serum IL-10 concentrations were analyzed from the fasted sample. All data were analyzed using PROC GLIMMIX of SAS, with dog as a random effect and week, diet group, and sampling time point as fixed effects for AA, and with dog as a random effect and week as a fixed effect and repeated measure for IL-10. There was no effect of treatment on any AA, though a significant Trt*wk*timepoint interaction effect was observed for His and Trp (P ≤ 0.05). An overall increase was observed in many AAs for all dogs-serum concentrations of Lys, Met, Thr, Trp, Ala, Arg, Gln, Gly, Pro, Ser, Tau, and Tyr were greatest at week 8 in all dogs when compared to concentrations at week -1 (P ≤ 0.05). Serum IL-10 concentrations did not differ by week or between groups (P > 0.05). In 3 Trt dogs that had greater gut permeability than all other dogs at week -2, as reported in a previous publication, serum Ile, Thr, and Val concentrations were greater at week 8 compared to week -1 (P ≤ 0.05) and Leu concentrations were greater 1 and 2 h postprandial at week 8 compared to the same time points at week -1 (P ≤ 0.05). The results of this study suggest that supplemental yeast may have a beneficial effect on peripheral AA availability without impacting inflammatory status in dogs. Future studies should seek to investigate the effects of reducing or improving gut permeability with yeast on nutrient digestive and metabolic efficiencies or consider yeast in clinical nutrition to support dogs with gastrointestinal diseases.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.